NRx Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Business Update
Four near-term milestones, including initiation of potential spinout initiatives expected in 2023/early 2024 Completing enrollment of the originally-targeted...
Source: prnewswire.com